WB
Various lysates were subjected to SDS PAGE followed by western blot with SREBF2 antibody at dilution of 1:2000 incubated at room temperature for 1.5 hours.IP
IP result of anti-SREBF2 (IP:4ug; Detection:1:1500) with HeLa cells lysate 1200 ug.| Product Name | SREBF2 Polyclonal antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Recombinant human SREBF2 protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IPWB |
| WB:1:1000-1:8000 IP:0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
|
| Species Reactivity | Human |
| Concentration | 0.5mg/ml |
| Purification | Affinity purified |
| Gene Symbol | SREBF2 |
|---|---|
| Gene Synonyms | SREBP2 bHLHd2 SREBP-2 |
| Gene Full Name | sterol regulatory element binding transcription factor 2 |
| Gene Summary | This gene encodes a member of the a ubiquitously expressed transcription factor that controls cholesterol homeostasis by regulating transcription of sterol-regulated genes. The encoded protein contains a basic helix-loop-helix-leucine zipper (bHLH-Zip) domain and binds the sterol regulatory element 1 motif. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013] |
| Alternative Names | bHLHd2 Class D basic helix-loop-helix protein 2 Processed sterol regulatory element-binding protein 2 SREBF 2 SREBP 2 |
| Molecular Weight(MW) | 124 kDa |
| Cellular Localization | Cytoplasmic vesicle,Endoplasmic reticulum,Golgi apparatus,Membrane,Nucleus |
WB
Various lysates were subjected to SDS PAGE followed by western blot with SREBF2 antibody at dilution of 1:2000 incubated at room temperature for 1.5 hours.
IP
IP result of anti-SREBF2 (IP:4ug; Detection:1:1500) with HeLa cells lysate 1200 ug.| Application Notes | WB:1:1000-1:8000 IP:0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20°C. Stable for one year after shipment. |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
